ORPHELIA Pharma will participate to the ANR 2023
Jeremy Bastid, Chief Development Officer at ORPHELIA Pharma will attend the Advances in Neuroblastoma Research (ANR) meeting to be held May 15-18, 2023 in Amsterdam, the Netherlands.
ORPHELIA Pharma will participate to the SIOPe 2023
We are pleased to announce that Jeremy Bastid, Chief Development Officer, and Hugues Bienaymé, General Manager and Chief Scientific Officer at ORPHELIA Pharma, will attend SIOP Europe 2023. We will be present at booth #10 located near the entrance doors to Auditorium 1.
One new project supported by our Foundation
In February 2023, our corporate Foundation and its Endowment Fund supported Animal’Hom
Three new projects supported by our Foundation
During the Board of Directors in december 2022, our corporate Foundation supported three new projects: Phoenix Attitude, Passerelle Ouest and Generation Cochlee.
Newsletter December 2022
The following pages will tell you all about the latest projects supported by the Foundation and provide you with updates on older ones
Three new projects supported by our Foundation
In October 2022, our corporate Foundation and its Endowment Fund supported Clubhouse, Douleurs sans Frontières and ACM Ballet.